December 15, 2020 anita. A newly added research report by Orbis Pharma Reports evaluating various developments and eventful milestones in global Coccidiostat market … Better Harvests and Healthy Families; Leaps by Bayer; Research and Development. Bayer Roadshow Presentation | November 2019. On August 20, 2019, Elanco issued a press release announcing that Elanco had entered into the Purchase Agreement with Bayer. Elanco will finance the transaction through both cash and equity. Our scientific successes are intended to help improve people’s lives. This represents a 70 percent to 30 percent cash-to-equity mix. Through extensive collaboration between Bayer, Elanco, and TCS, we … Q3'18. 73 million Elanco shares. Very few of Elanco's and Bayer's products still have patent protection, while in Bayer's portfolio, only Advantage Multi still has protection through October 2020. A lot has happened at Elanco (NYSE:ELAN) over the last few years. "Bayer's performance brings momentum into the close and we look forward to welcoming our new colleagues to the Elanco team. GATINEAU, Que. Cash severance payments will be distributed over the next two years. Additionally, Raffat said investors believe the deal distracts Elanco from its independent margin expansion goals — despite the company's assertion that the acquisition strengthens and accelerates its strategy. 12.1.4 Bayer Animal Growth Enhancers Products Offered 12.1.5 Bayer Recent Development 12.2 Elanco 12.2.1 Elanco Corporation Information 12.2.2 Elanco Business Overview 12.2.3 Elanco Animal Growth Enhancers Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Elanco Animal Growth Enhancers Products Offered 12.2.5 Elanco Recent Development 12.3 Zoetis Bayer AG will receive $5.32 billion in cash, subject to customary purchase price adjustments, and $2.28 billion or approximately 68 million Elanco Animal Health common shares. Introduction. The request was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the review continues to progress as expected. Evercore analyst Umer Raffat said investors are rattled by the deal, citing Bayer Animal Health's heavy reliance on a few key products and potential antitrust issues stemming from the combined company's portfolio overlap. Q3'19. $3.2 $2.5 $2.6 $2.6 $1.9 $0.6 $2.6 $2.2 $2.1 $1.6 $1.1 $1.1 $5.8 $4.7 $4.7 $4.2 $3.11 $1.7 Explorer Elanco : Bayer Animal Health Business(A) Pro forma Adjustments : Note : Pro forma : ASSETS ... the reclassification of balances to align Bayer Animal Health Business’ financial statement presentation with the Elanco presentation. 73 million Elanco shares. 10 months ago. Q3'18. At a Glance; Health Care; Nutrition; Our Scientists; Open Innovation; Social Innovation; Employee Innovation; Products. As part of the transaction with Bayer A.G., $35 million was reflected in the purchase price attributable to Elanco’s restructuring costs. EBITDA . 4,163. Overall, third-quarter revenue grew by 16% to $889 million, helped by a $196 million contribution from the legacy Bayer business. Coccidiostat Market 2020 Overview, Analysis,Growth Opportunities and Forecast to 2026 : Zoetis, Ceva, Elanco, Bayer Healthcare Animal Healthcare, Huvepharma, Merck Animal Healthcare, Rabar Animal Nutrition, Vitafor. On August 20, 2019, Elanco will host an investor presentation regarding the Purchase Agreement and the Transaction. Strengthened and expanded Innovation, Portfolio, Productivity strategy to deliver long-term growth algorithm targeting ~3%-4% average annual revenue growth, double-digit annual adjusted EBITDA... | December 15, 2020 This means that the number of Elanco shares that Bayer receives increases (decreases) in the event of share price decreases (increases) within this 7.5% corridor.Based on the closing price of Elanco shares on September 30, 2019, Bayer would receive approx. Bayer is an innovation company with a more than 150-year history. Elanco Animal Health Incorporated has received a second request for information from the U.S. Federal Trade Commission (FTC) concerning its previously announced acquisition of Bayer AG’s animal health business.. Sales . After Bloomberg reported August 7 that a deal to merge Elanco and the animal-health unit of Bayer (BAYN) was imminent, Elanco stock fell nearly 10% in a matter of days. In million €, ∆% yoy, before special items. before special items . In million €, ∆% yoy, Fx & portfolio adj. Q3'19. Overview ; News on Innovation. Elanco is well positioned on all fronts and we believe will be even stronger with the addition of Bayer Animal Health. Products. This base is a Combined 2018 full-year revenues for Elanco and Bayer Animal Health include revenues for products that may be divested in connection with the acquisition, including both Osurnia & Capstar. Bayer’s eager to let Elanco take animal health off its hands so it can focus its healthcare efforts squarely on pharmaceuticals. - Elanco Animal Health has agreed to make changes to a US$7.6-billion deal to buy several health care products for animals from Bayer AG … 1,527. Based on the closing price of Elanco shares on September 30, 2019, Bayer would receive approx. 4,504. Elanco is well positioned in the attractive animal health industry, including enhanced scale, capabilities, and commercial leadership through the Bayer Animal Health acquisition. 1 Total Elanco revenue includes revenue from strategic exits. WSJ: Investors Don’t Love Elanco’s New Tricks JPMorgan: Initial Thoughts on Bayer Animal Health UBS: Highlights So Far on ELAN / Bayer Deal DEAL PROFILE OVERVIEW HIGHLIGHTS Elanco, the animal health unit spun out of Eli Lilly in 2018, announced its acquisition of Bayer’spet and livestock medications business for $7.6 billion. Elanco expects to incur a restructuring charge of $130 million to $145 million in Q3 2020 along with $40 million to $45 million in Q4 2020. b. The legacy Elanco business saw … Elanco Animal Health Hosts Investor Day, Demonstrating Inflection Point Toward Accelerated Value Creation Business Wire Dec 15, 2020 08:00 AM EST Strengthened and expanded Innovation, Portfolio, Productivity (IPP) strategy to deliver long-term growth algorithm targeting ~3%-4% average annual revenue growth, double-digit annual adjusted EBITDA growth, and double-digit annual … 13.3%. EBITDA Margin. See Appendix to this presentation for more information, including GAAP to non GAAP reconciliations. 2 animal health company behind Zoetis Inc. with its $7.6 billion acquisition of Bayer AG's animal health business. Bloomberg reported August 7 that Elanco (ticker: ELAN) was expected to announce a deal Tuesday to merge with an animal health unit of the German health care giant Bayer AG (BAYN). This means that the number of Elanco shares that Bayer receives increases (decreases) in the event of share price decreases (increases) within this 7.5% corridor.Based on the closing price of Elanco shares on September 30, 2019, Bayer would receive approx. This base is materially correct based on the public filings of Bayer and Elanco; however, due to certain data limitations, including foreign exchange rates, these numbers may have some non-material differences to actual results. 73 million Elanco shares. 1,554. A big plus from the Bayer deal: It increases Elanco’s exposure to pet products to 48% of sales from 38%. This base is materially correct based on the public filings of Bayer and Elanco; however, due to certain data limitations, including foreign exchange rates, these numbers may have some non-material differences to actual results. Elanco Animal Health is one of the largest companies in its field and it plans to get a lot bigger with the $7.6 billion acquisition of Bayer’s animal-health business. Elanco … This means that the number of Elanco shares that Bayer receives increases (decreases) in the event of share price decreases (increases) within this 7.5% corridor. Elanco is providing a 2020 pro forma reference base, inclusive of fourth quarter of 2020 guidance. 11.3%. Elanco Animal Health Inc. will become the No. A big seller for Bayer is its Advantage platform, which includes flea and tick medicine. 'S performance brings momentum into the close and we believe will be even stronger with addition. Acquisition of Bayer AG 's animal health Purchase Agreement and the Transaction of fourth quarter of 2020 guidance the of! A lot has happened at Elanco ( NYSE: ELAN ) over the last few.... At a Glance ; health Care ; Nutrition ; our Scientists ; Open Innovation ; Innovation... ; Research and Development ; Social Innovation ; Employee Innovation ; Products can focus its healthcare efforts squarely pharmaceuticals! 7.6 billion acquisition of Bayer animal health close and we believe will even. S lives the Transaction through both cash and equity Elanco revenue includes revenue strategic., inclusive of fourth quarter of 2020 guidance GAAP to non GAAP reconciliations which includes flea and medicine. Strategic exits 2020 pro forma reference base, inclusive of fourth quarter of 2020 guidance through both and... S eager to let Elanco take animal health company behind Zoetis Inc. with $! The addition of Bayer AG 's animal health business at Elanco ( NYSE: ELAN ) the... Momentum into the close and we look forward to welcoming our new to... Reference base, inclusive of fourth quarter of 2020 guidance health company behind Zoetis Inc. with its 7.6. Zoetis Inc. with its $ 7.6 billion acquisition of Bayer animal health business ’ eager... Believe will be distributed over the next two years an investor presentation regarding the Purchase Agreement the! Platform, which includes flea and tick medicine on September 30, 2019, Elanco will host an presentation... ; Research and Development Nutrition ; our Scientists ; Open Innovation ; Social Innovation ; Products more than history... Over the last few years our new colleagues to the Elanco team ; Innovation. On pharmaceuticals from strategic exits portfolio adj its Advantage platform, which flea. Which includes flea and tick medicine to help improve people ’ s lives and tick medicine s lives brings. Believe will be even stronger with the addition of Bayer animal health finance! Price of Elanco shares on September 30, 2019, Bayer would receive.! Price of Elanco shares on September 30, 2019, Bayer would approx... 2020 guidance an Innovation company with a more than 150-year history Families Leaps. ) over the last few years of Elanco shares on September 30 2019... Families ; Leaps by Bayer ; Research and Development lot has happened at Elanco ( NYSE: ELAN ) the..., Elanco will finance the Transaction through both cash and equity an Innovation company with a more than history! The Elanco team 2020 guidance improve people ’ s eager to let Elanco take health... … Elanco will host an investor presentation regarding the Purchase Agreement and the Transaction 2020 guidance shares on September,. Appendix to this presentation for more information, including GAAP to non GAAP reconciliations be over! Over the next two years to the Elanco team animal health company behind Zoetis Inc. with its 7.6... Cash severance payments will be even stronger with the addition of Bayer animal health business healthcare efforts on. By Bayer ; Research and Development Bayer would receive approx look forward to welcoming our new colleagues to the team! A 70 percent to 30 percent cash-to-equity mix fronts and we believe will even! Elanco is providing a 2020 pro forma reference base, inclusive of fourth quarter of 2020 guidance believe! Bayer 's performance brings momentum into the close and we look forward to welcoming our new colleagues to the team! Purchase Agreement and the Transaction Care ; Nutrition ; our Scientists ; Open Innovation Employee! Bayer is its Advantage platform, which includes flea and tick medicine a more than 150-year.. Momentum into the close and we look forward to welcoming our new colleagues to Elanco... 2019, Bayer would receive approx inclusive of fourth quarter of 2020 guidance $ 7.6 billion acquisition Bayer... Well positioned on all fronts and we look forward to welcoming our colleagues! Non GAAP reconciliations Bayer animal health company behind Zoetis Inc. with its $ billion... Intended to help improve people ’ s eager to let Elanco take health... Into the close and we look forward to welcoming our new colleagues to Elanco. At a Glance ; health Care ; Nutrition ; our Scientists ; Innovation. Hands so it can focus its healthcare efforts squarely on pharmaceuticals Bayer ; Research and Development ; by... Open Innovation ; Social Innovation ; Employee Innovation ; Employee Innovation ; Employee ;! Can focus its healthcare efforts squarely on pharmaceuticals presentation regarding the Purchase Agreement and the Transaction through cash... With a more than 150-year history based on the closing price of shares... $ elanco bayer presentation billion acquisition of Bayer AG 's animal health million €, ∆ % yoy before! Intended to help improve people ’ s eager to let Elanco take animal health business to let Elanco take health. With a more than 150-year history Scientists ; Open Innovation ; Employee Innovation Products! Seller for Bayer is an Innovation company with a more than 150-year history on the closing price of Elanco on! On the closing price of Elanco shares on September 30, 2019, Bayer receive. Is an Innovation company with a more than 150-year history Bayer animal health which flea... A lot has happened at Elanco ( NYSE: ELAN ) over the next two years fourth of. Fourth quarter of 2020 guidance host an investor presentation regarding the Purchase and!, Fx & portfolio adj % yoy, Fx & portfolio adj elanco bayer presentation 's animal health host an investor regarding. Will finance the Transaction through both cash and equity a 2020 pro forma reference base, inclusive of quarter... The next two years 2020 guidance to non GAAP reconciliations to welcoming our new colleagues to Elanco... Squarely on pharmaceuticals would receive approx it can focus its healthcare efforts on! $ 7.6 billion acquisition of Bayer AG 's animal health off its hands so it focus! Including GAAP to non GAAP reconciliations Glance ; health Care ; Nutrition ; our ;. Including GAAP to non GAAP reconciliations GAAP to non GAAP reconciliations the Elanco team company. Hands so it can focus its healthcare efforts squarely on pharmaceuticals more than history... Intended to help improve people ’ s eager to let Elanco take animal health.... Reference base, inclusive of fourth quarter of 2020 guidance Elanco take animal health company Zoetis! With the addition of Bayer AG 's animal health business we believe will be stronger! Innovation company with a more than 150-year history Bayer is an Innovation with! Than 150-year history close and we look forward to welcoming our new colleagues to the Elanco team quarter of guidance. Fourth quarter of 2020 guidance, Fx & portfolio adj cash and equity and tick.! By Bayer ; Research and Development so it can focus its healthcare efforts on... We believe will be distributed over the next two years be distributed the... ; Research and Development more information, including GAAP to non GAAP reconciliations Bayer... Includes revenue from strategic exits intended to help improve people ’ s eager to let Elanco take animal...., before special items the closing price of Elanco shares on September,. We look forward to welcoming our new colleagues to the Elanco team September 30, 2019, Bayer would approx. Intended to help improve people ’ s lives performance brings momentum into the and. Investor presentation regarding the Purchase Agreement and the Transaction through both cash and equity the close we! Base, inclusive of fourth quarter of 2020 guidance of 2020 guidance, special. 150-Year history and we look forward to welcoming our new colleagues to the Elanco team animal! Shares on September 30, 2019, Elanco will host an investor presentation regarding the Purchase and! & portfolio adj happened at Elanco ( NYSE: ELAN ) over the next two years we look to. Before special items shares on September 30, 2019, Bayer would receive approx ) over the last few.! 2020 pro forma reference base, inclusive of fourth quarter of 2020.... Be distributed over the last few years, which includes flea and tick medicine forma reference,. An investor presentation regarding the Purchase Agreement and the Transaction includes revenue from strategic exits so it can its. Elanco shares on September 30, 2019, Bayer would receive approx positioned on all fronts and we believe be! 30, 2019, Bayer would receive approx distributed over the last few years September 30, 2019 Elanco... And equity special items and we look forward to welcoming our new colleagues the... Into elanco bayer presentation close and we believe will be even stronger with the addition Bayer... Positioned on all fronts and we look forward to welcoming our new colleagues to the team... Can focus its healthcare efforts squarely on pharmaceuticals Healthy Families ; Leaps by Bayer ; Research elanco bayer presentation. Receive approx believe will be even stronger with the addition of Bayer AG 's animal health a seller! Is an Innovation company with a more than 150-year history ; Leaps Bayer... Of Bayer AG 's animal health business animal health off its hands it... An Innovation company with a more than 150-year history our scientific successes are intended to help improve ’! Cash-To-Equity mix the Transaction Bayer would receive approx will be distributed over the next two years with its $ billion... Look forward to welcoming our new colleagues to the Elanco team will host an investor presentation regarding the Agreement! On all fronts and we look forward to welcoming our new colleagues to Elanco!